Artificial Intelligence‐Driven Precision Bisphosphonate Therapy in Osteoporosis: Mechanisms, Clinical Applications, Risks, and Future Directions
Xiang Yao, Yicong Chao, Xiao Gu, Jingtao Peng, Jishan Yuan, Wei Shi, Fuguo Zhang, Qiwen Bao · 2026
Read Artificial Intelligence‐Driven Precision Bisphosphonate Therapy in Osteoporosis: Mechanisms, Clinical Applications, Risks, and Future Directions by Xiang Yao, Yicong Chao, Xiao Gu, Jingtao Peng, Jishan Yuan, Wei Shi, Fuguo Zhang, Qiwen Bao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13585479.txt.
Description
Xiang Yao and co-authors review how artificial intelligence could tailor bone-protecting drugs to each patient, in a 2026 paper. Bisphosphonates are the standard treatment for osteoporosis, but diagnosis lags, responses vary, and rare harms like jaw bone death worry doctors. The team searched three major databases across twenty years of work at the meeting point of these drugs and computing.
They map four uses. Learning systems can scan routine CT images to catch silent spine fractures and grade bone quality. They can forecast who will gain bone density and who should switch drugs. They can flag patients at risk of the rare harms before they strike. And modeling can design carriers that deliver the drug to bone with less spill. Gaps in openness and validation remain.
Catalog record
| CREATOR | Xiang Yao, Yicong Chao, Xiao Gu, Jingtao Peng, Jishan Yuan, Wei Shi, Fuguo Zhang, Qiwen Bao |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |